Area of research
Oncology · Infectious Diseases
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research, vaccines and immunoinformatics approaches, and Influenza Virus Research Studies.
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer
Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
Fundamental immune–oncogenicity trade-offs define driver mutation fitness
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Introductions and early spread of SARS-CoV-2 in the New York City area
COVID-19 in patients with lung cancer
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology